Re: Minimally Invasive Therapy Using Intralesional OnabotulinumtoxinA in Peyronie's Disease.
Clinical Center for Urological Disease Diagnosis and Private Clinic Specializing in Urological and Andrological Genetics, Tehran, Iran.. info@safarinejad.com.
Mohammad Reza
MR
Safarinejad
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D010410:Penile Erection / Q000187:drug effects*; D010411:Penile Induration / Q000188:drug therapy*
D019274:Botulinum Toxins, Type A